| 000 | 01355 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512081612.0 | ||
| 264 | 0 | _c19860418 | |
| 008 | 198604s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCavallin-Ståhl, E | |
| 245 | 0 | 0 |
_aPrednimustine v cyclophosphamide-vincristine-prednisolone in the treatment of non-Hodgkin's lymphoma with favorable histopathology: results of a national cancer care program in Sweden. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cMar 1986 |
||
| 300 |
_a19-22 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aChlorambucil _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCyclophosphamide _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednimustine _xadverse effects |
| 650 | 0 | 4 |
_aPrednisone _xadverse effects |
| 650 | 0 | 4 | _aSweden |
| 650 | 0 | 4 |
_aVincristine _xadverse effects |
| 700 | 1 | _aMöller, T R | |
| 773 | 0 |
_tSeminars in oncology _gvol. 13 _gno. 1 Suppl 1 _gp. 19-22 |
|
| 999 |
_c3958203 _d3958203 |
||